OBINUTUZUMAB (GA101) OR RITUXIMAB (R) plus CHLORAMBUCIL (CLB) VERSUS CLB ALONE IN PATIENTS WITH CLL AND PRE-EXISTING MEDICAL CONDITIONS (COMORBIDITIES): FINAL STAGE 1 RESULTS OF THE CLL11 PHASE 3 TRIAL
HAEMATOLOGICA（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要